Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Novartis
Incyte Corporation
Checkpoint Therapeutics, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Candel Therapeutics, Inc.
Quadriga Biosciences, Inc.
A&G Pharmaceutical Inc.
Shionogi Inc.
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Bayer
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Chicago
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute